IQVIA director granted 160 deferred shares

DANHAKL JOHN G reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

DANHAKL JOHN G reported acquisition or exercise transactions in this Form 4 filing.

IQVIA Holdings Inc. director John G. Danhakl received a grant of 160 deferred shares on 2026-07-14, representing rights to an equal number of common shares upon settlement. Under the Non-Employee Director Deferral Plan, these units settle when he leaves the board, upon a change in control, or upon death. Following the award, he holds 3,289 deferred shares directly.

Insider Trade Summary

Grant/Award: 160 shares

Grant/Award 1 txn

Insider DANHAKL JOHN G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Shares F1	160	$207.83	$33K

Holdings After Transaction: Deferred Shares — 3,289 contracts (Direct)

Footnotes (1)

1. F1. Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Key Figures

Deferred shares granted: 160 deferred shares Reference price per deferred share: $207.83 Deferred shares after transaction: 3,289 deferred shares +1 more

4 metrics

Deferred shares granted 160 deferred shares Grant to director John G. Danhakl on 2026-07-14

Reference price per deferred share $207.83 Value used in the award of deferred shares

Deferred shares after transaction 3,289 deferred shares Total deferred share holdings following the award

Underlying common stock per deferred share 1 share Each deferred share convertible into one share of common stock

Key Terms

Deferred Shares, Non-Employee Director Deferral Plan, change in control

3 terms

Deferred Shares financial

"Each deferred share is convertible into one share of common stock"

Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.

Non-Employee Director Deferral Plan financial

"in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting"

change in control financial

"when the reporting person ceases to be a director, upon a change in control"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did IQV director John G. Danhakl report in this insider filing?

He reported receiving a grant of 160 deferred shares tied to IQVIA common stock. These are compensation units, not an open-market purchase, and convert into common shares only when settlement conditions under the director deferral plan are satisfied.

How many IQV deferred shares were granted to John G. Danhakl and at what price?

John G. Danhakl was granted 160 deferred shares with a reference value of $207.83 per unit. This figure reflects the price used to measure the award’s value, not cash paid in a market transaction.

When do the IQV deferred shares granted to John G. Danhakl become settleable?

The deferred shares settle when he ceases to be a director, upon a change in control of IQVIA, or upon his death. At settlement, each deferred share converts into one share of common stock.

What is John G. Danhakl’s total IQV deferred share holding after this grant?

After the award, John G. Danhakl directly holds 3,289 deferred shares. Each deferred share is convertible into one share of IQVIA common stock upon settlement under the Non-Employee Director Deferral Plan.

Do the IQV deferred shares reported by John G. Danhakl have an expiration date?

The filing states there is no expiry date for these deferred shares. They remain outstanding until settlement, which occurs upon board departure, a change in control, or the reporting person’s death.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/16/2026 - 05:02 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DANHAKL JOHN G

(Last) (First) (Middle)

C/O IQVIA HOLDINGS INC.

2400 ELLIS ROAD

(Street)

DURHAM NORTH CAROLINA 27703

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Shares	(1)	07/14/2026		A		160		(1)	(1)	Common Stock	160	$207.83	3,289	D

Explanation of Responses:

1. Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Remarks:

Power of Attorney

	/s/ Abigail Jeck, Attorney-in-Fact for John G. Danhakl	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)